Abstract: A modified metal complex obtained by subjecting a metal complex containing an organic compound having one nitrogen-containing aromatic heterocycle and four or more structures of a phenol, thiophenol, aniline or nitrogen-containing aromatic heterocyclic ring or an organic compound having two or more phenol rings and three or more nitrogen-containing aromatic heterocycles, in its molecule as a ligand, to a heating, radiation irradiation or discharge treatment until a mass reduction rate after the treatment becomes from 1 to 90 mass %, thereby the complex shows a carbon content after the treatment of 5 mass % or more.

Abstract: It is intended to provide a method by which a substance having a phosphate group can be easily detected from a biological sample or the like, a method by which a phosphorylated amino acid residue is easily identified and a compound which can be used in the methods because of having a high coordinate bond forming capacity with a substance having a phosphate group.

Abstract: Provided is an organometallic complex that highly effectively emits a phosphorescent light and an organic electroluminescent device using the same. The organometallic complex can be used to form an organic layer of an organic electroluminescent device, is a highly effective phosphorescent material emitting light of 400 nm to 650 nm, and can be used with a green emission material or a red emission material to emit a white light. In addition, the organometallic complex can be used in a solution process due to its high solubility, and thus, is suitable for large-scale screens.

Abstract: The present invention relates to chelating agents, in particular to chelating agents which are capable of forming complexes with paramagnetic metal ions such as iron (III) and gadolinium (III). The invention also relates to the complexes formed and their use as MRI contrast agents.

Abstract: Zinc pyrithione and copper pyrithione are highly evaluated in the market as an antidandruff agent for shampoo, or an antifouling agent for ship bottom paint and fish-farming net, or an antibacterial/antifungal agent or preservative/mildewcide for industrial products and household articles. For enhancing the market value thereof, there has been a demand for a product that not only attains an increase in conventional antibacterial/antifungal effects but also exhibits novel bioactive effects and that achieves improvement with respect to problems and drawbacks relating to properties, such as solubility in seawater, and stability, such as thermal stability and weather resistance, of polymer materials. There is provided a novel pyrithione complex compound obtained by converting the conventional pyrithione metal salt to a complex compound with an oxide or hydroxide of metal such as zinc, copper or aluminum.

Abstract: The present invention provides luminescent complexes between a lanthanide ion and an organic ligand which contains 1,2-hydroxypyridinone units. The complexes of the invention are stable in aqueous solutions and are useful as molecular probes, for example in medical diagnostics and bioanalytical assay systems. The invention also provides methods of using the complexes of the invention.

Abstract: A light emitting device having at least one layer that contains a phosphorescent organometallic dendrimer with a metal cation and two or more coordinating groups as part of its core and wherein at least two of said coordinating groups each have a dendron attached, at least one of which dendrons comprises at least one nitrogen atom which forms a part of an aromatic ring system or is directly bonded to at least two aromatic groups.

Abstract: A photosensitized composite material and a material, an element, a device, and the like, which employ the photosensitized composite material, are provided. In the photosensitized composite material, multiphoton absorption compounds are highly sensitized for practical use by utilizing an enhanced plasmon field. The photosensitized composite material has a structure where the multiphoton absorption compounds are linked to the surface of a fine metal particle through linking groups. The fine metal particle generates an enhanced surface plasmon field in resonance with a multiphoton excitation wavelength. The multiphoton absorption compounds have a molecular structure enabling multiphoton absorption.

Abstract: A coating liquid including one or more of metal complexes selected from a metal complex A represented by Chemical Formula 1, a metal complex B represented by Chemical Formula 2, and a metal complex C represented by Chemical Formula 3. M in Chemical Formula 1, Chemical Formula 2 and Chemical Formula 3 represents a metal ion. Each of X1-X4 in Chemical Formula 1, Chemical Formula 2 and Chemical Formula 3 is one of O, NH, CO2 and S. Each of Y1-Y8 in Chemical Formula 1 and Y1-Y4 in Chemical Formula 3 is either CH or N. Each of Z1-Z3 in Chemical Formula 2 and Chemical Formula 3 and Z4-Z6 in Chemical Formula 2 is one selected from a group of O, NH and S, and two selected from a group of CH and N. L in Chemical Formula 1, Chemical Formula 2 and Chemical Formula 3 represents an axial ligand. k in Chemical Formula 1, Chemical Formula 2 and Chemical Formula 3 represents a valence of each of the metal complexes and is equal to a sum of electric charges of M, X1-X4 and L.

Abstract: An objective of this invention is to extend the range of choosing organic dye compounds as light-absorbing agent in a variety of fields of, for example, information storage, information display, solar energy generation, electric machinery apparatus, electric communicating apparatus, optical apparatus, cloth, building/bedding/decorating product, sanitary and health goods, and agricultural material by providing an organic dye compound which is superior in light-absorbing property, light resistance, and solubility in the near-infrared region: The objective is attainable by providing a cyanine dye that bears within the same molecule a plurality of cyanine dye skeletons bound to a divalent group(s) and an organometallic complex as counter ion, as well as substantially absorbing a light with a wavelength longer than 700 nm.

Abstract: The invention is reversibly reducible metal complexes and materials and an organic light emitting device, having an anode; a cathode; and at least one organic layer disposed between the anode and the cathode, made with the complexes of the invention. The reversibly reducible metal complexes are complexes a redox active metal center and at least one ligand; wherein; following a reduction of the complex, adding 1 extra electron to the complex, the extra electron is localized on the metal center. The complexes may function as an ETL or a host material.

Abstract: The present application is directed to complexes according to Formulae (I) or (II) as described herein, and their use as redox mediators in electrochemical biosensors.

Abstract: This invention relates a method for the preparation of platinum(II)oxalato complexes from their dihalogenoplatinum(II) precursors having either neutral monodentate or bidentate non-leaving co-ligands. Of particular interest is oxaliplatin. The method includes the step of reacting a halogenoplatinum(II) complex containing a neutral monodentate or bidentate ligand with an oxalate in a non-aqueous solvent or a mixed solvent system. The mixed solvent system is solvent mixture containing a non-aqueous solvent and water. According to the present invention, the non-aqueous solvent is an alcohol.

Abstract: Provided are a novel hydrazide chelate complex compound which is excellent in terms of both solubility in a coating solvent and light fastness, which can be used for blue laser recording, and which is useful as a dye for forming a recording layer of an optical recording medium, the hydrazide chelate complex compound being represented by general formula (1) below; and a dye for forming a recording layer of an optical recording medium, the dye containing the compound. In general formula (1), ring A represents an aromatic ring; R1 and R6 each represent an aromatic ring group or a monovalent nonaromatic ring substituent having 20 or less carbon atoms; R2 to R5 each represent a hydrogen atom, an aromatic ring group, or a monovalent nonaromatic ring substituent having 20 or less carbon atoms; n represents 0 or 1; a represents an integer of 1 to 3; M represents a transition metal atom; and X represents an atom of Groups 14 to 16 of the periodic table.

Abstract: The present invention relates to an organic electroluminescent device comprising an organic layer interposed between an anode and an cathode on a substrate, wherein the organic layer comprises an electroluminescent layer comprising one or more host compound(s) represented by Chemical Formula (1) and one or more dopant compound(s) represented by Chemical Formula (2): The organic electroluminescent device according to the present invention exhibits long life, high efficiency and high luminance with good color purity and lowered operation voltage, as well as enhanced stability of device.

Abstract: This invention relates to a light emitting device which comprises at least one layer that contains an organometallic dendrimer having a core comprising a metal cation. The invention also relates to organometallic dendrimers and methods for producing the same.

Abstract: The present invention has an object to widen the range of applicable field of organic compounds to be selected as light absorbing materials in various fields including information recordings, solar energy generations, electric machinery apparatuses, electric communicating apparatuses, optical apparatuses, clothes, building/bedding/decorating products, sanitary and health goods, and agricultural materials, particularly, in the field of optical recording media by providing novel organic materials which absorb short-wavelength visible light, have improved lightfastness and solubility in solvents, and also have heat characteristics depending upon uses to be applied. The object is attained by providing cyanine dyes having a specific structure.

Abstract: The invention comprises neutral multi-functionality assemblies of pharmaceuticals comprising an active medicinal functionality, a transition metal functionality, and an ancillary ligand functionality. An exemplary series of mixed-ligand coordination complexes comprised of copper(II), a drug and an ancillary ligand were made and tested. It is demonstrated that the judicious choice of an ancillary ligand affords a large degree of control over die relative lipophilicity/hydrophilicity of the complex in relation to the uncomplexed drug molecule. The important factors to be considered in the design of such complexes, such as the additive-constitutive nature of the partition coefficient of the ancillary ligand and the relative size of the two types of ligands are disclosed, and methods of designing neutral multi-functionality assemblies of pharmaceuticals are disclosed.

Abstract: Disclosed herein are novel zinc ionophores, zinc chelators and/or zinc complexes with enhanced aqueous solubility. Methods of treating cancer using at least one zinc ionophore and/or zinc chelator are also disclosed. Also disclosed herein are compositions and methods for treating cancer with combination therapy using at least one texaphyrin metal complex and at least one zinc ionophore or the respective pharmaceutically acceptable derivatives or salts thereof.

Abstract: The present invention provides an organic electroluminescent element having at least one organic layer including a luminescent layer between a pair of electrodes wherein at least one organic layer contains a metal complex of cyclic tetradentate ligand having a specific structure.

Abstract: A high-efficient phosphorescent iridium (III) complex with a heteroatom linking group and an organic electroluminescent (EL) device using the same. The iridium complex is represented by Formula 1 or Formula 2: The iridium complex of the present invention complex can efficiently emit light ranging from a blue region to a red region in a triplet MLCT state. The iridium (III) complex can be used in formation of an organic layer of an organic EL device. Since the iridium complex of the present invention can be used as a high-efficiency phosphorescent material, the iridium complex of the present invention can produce white light emission when used together with a green-emitting material or a red-emitting material as well as emission at the wavelength range of 400-650 nm.

Abstract: An organometallic complex is represented by Formula (1) below. MLmL?n ??(1) In Formula (1) M stands for Ir, Rh, Pt, or Pd, m is an integer of 1 to 3, and n is an integer of 0 to 2, where m+n=3. MLm denotes a partial structure represented by Formula (2) below. ML?n denotes a partial structure represented by at least one of Formulas (3) to (5) below.

Abstract: An organic EL element includes an organometallic complex including a rhenium atom; one ligand which has a coordinated nitrogen atom and a coordinated oxygen atom, each coordinated with the rhenium atom, and has at least one ? conjugation part; and the other ligand coordinated with the rhenium atom in such a way that the ligand saturates the coordination number of the rhenium atom and the charge of the whole organometallic complex is neutral.

Abstract: The present invention describes novel metal complexes. Compounds of this type can be employed as functional materials in a number of different applications which can be ascribed to the electronics industry in the broadest sense. The compounds according to the invention are described by the formulae (1) and (1a).

Abstract: Disclosed herein are novel zinc ionophores, zinc chelators and/or zinc complexes with enhanced aqueous solubility. Methods of treating cancer using at least one zinc ionophore and/or zinc chelator are also disclosed. Also disclosed herein are compositions and methods for treating cancer with combination therapy using at least one texaphyrin metal complex and at least one zinc ionophore or the respective pharmaceutically acceptable derivatives or salts thereof.

Abstract: The present invention relates to electroluminescent compounds represented by Chemical Formula (1) L1L1M(Q)m and electroluminescent devices comprising the same as host material. The electroluminescent compound according to the invention, when used as host material of an OLED, noticeably lowers the operation voltage and enhance the power efficiency.

Abstract: A phosphorescent OLED uses a phosphorescent dopant in the emissive layer, the dopant includes a metal complex containing a plurality of moieties linking to a transition metal ion. One or more of the moieties contain a ligand with a C—SP3 carbon center. The transition metal ion can be an iridium ion. The C—SP3 carbon is linked to a chalcogen atom in an ion form, a nitrogen-containing heterocylic ring and two functional groups, wherein each of the functional groups is selected from aryl, alkyl and heteroaryl. The tetrahedral structure of this carbon center hinders close packing and intermolecular interactions and, therefore, renders the transport of holes in the light-emitting device more efficient. With such chemical structure and property, the self-quenching characteristics of the dopant in high doping concentration can be effectively reduced.

Abstract: A polymer carrier to which a prescribed zinc complex group is binding directly or through a spacer, having property to bond, under a certain condition, to an anionic substituent (a phosphate group, for example), showing low solubility to a solvent (preferably insolubility to a solvent) as a whole, and being capable of capturing, separating and purifying easily a substance having an anionic substituent (a phosphate group, for example).

Abstract: Provision of a novel platinum complex which is useful as a material for a light-emitting device of good light emission characteristic and light emission efficiency, and a novel light-emitting material that may be utilized in various fields. A platinum complex represented by the following general formula (1): (in which two rings of ring A, ring B, ring C, and ring D represent nitrogen-containing heterocyclic rings which may have a substituent and the remaining two rings of them represent aryl rings or hetero aryl rings which may have a substituent, the ring A and the ring B, the ring A and the ring C or/and the ring B and the rind D may form condensed rings. Two of X1, X2, X3, and X4 represent nitrogen atoms coordination bonded to a platinum atom and the remaining two of them represent carbon atoms or nitrogen atoms.

Abstract: An organic electroluminescent device is provided and includes: a pair of electrodes; and an organic compound layer between the pair of electrodes, the organic compound layer including a light-emitting layer. The at least one organic compound layer contains at least one of a compound represent by formula (I) and a compound represented by formula (II).

Abstract: A new class of luminescent iridium(III) complexes, luminescent material and organic electroluminescent device thereof had been disclosed. The novel luminescent iridium(III) complexes comprises the formula [(C?N)2Ir(P?O)] with 2-(diphenylphosphino)phenolate as the ancillary chelate. The iridium complexes of the present invention can be used as the red, blue or green-emitting dopants. These luminescent materials can be applied in the fabrication of light-emitting layer of organic electroluminescent devices and providing the high efficiently red, blue or green light organic electroluminescent devices of commercial pursuits.

Abstract: A white or whitish luminescent material for phosphorescence is provided by synthesizing an organometallic complex that is able to convert a triplet excited state into light emission. In particular, a white electroluminescent device that has a high luminous efficiency and can be manufactured easily is provided by using the organometallic complex to manufacture a white or whitish electroluminescent device. The electroluminescent device is used to provide a light-emitting device with low power consumption. A fluorescent and phosphorescent material represented by a general formula (2) is synthesized.

Abstract: This invention relates to a transition metal catalyst compound represented by the structure: wherein: each X is, independently, a hydride, a halogen, a hydrocarbyl, a substituted hydrocarbyl, a halocarbyl, or a substituted halocarbyl; w is 2; each R1, R2, R3, and R4 is, independently, a hydrogen, a hydrocarbyl, a substituted hydrocarbyl, a halocarbyl, a substituted halocarbyl, a halogen, an alkoxide, a sulfide, an amide, a phosphide, a silyl or another anionic heteroatom-containing group, or independently, may join together to form a C4 to C62 cyclic or polycyclic ring structure; each R5, R6, and R7 is, independently, a hydrogen, a hydrocarbyl, a substituted hydrocarbyl, a halocarbyl, a substituted halocarbyl, a halogen, an alkoxide, a sulfide, an amide, a phosphide, a silyl or another anionic heteroatom-containing group, or independently, may join together to form a C4 to C62 cyclic or polycyclic ring structure; each R8 and R9, is, independently, a hydrogen, a hydrocarbyl, a substituted hydrocarbyl, a ha

Abstract: The present invention provides a diarylaminofluorene chromophore compound having the following structure: wherein: M is a metal atom of Ir, Pt; R is H or any substituent such as CH3, OCH3, F; A is none or six-member aromatic ring system; m is at least 1; n is at least zero. The invention also provides high-efficiency organic light-emitting devices fabricated using these compounds.

Abstract: The invention relates to intermediate compounds of the formula wherein R1 is H or a protecting group, R2 and R3 each independently represent H, methyl, or a leaving group, provided that at least one, but not both, of R2 and R3 is a leaving group. The intermediate compounds are useful for the synthesis of discodermolide, its derivatives, and related compounds.

Abstract: A process for forming the facial isomer of an aluminum trisquinoline complex comprises heating the solid aluminum trisquinoline complex material at a temperature at least 50° C. below the melting point temperature of the solid for a time sufficient to convert the aluminum trisquinoline complex to at least 99 mol % of one polymorph of the facial-isomer that fluoresces with a maximum intensity below 510 nm.

Abstract: The invention relates to intermediate compounds of the formula wherein R1 is H or a protecting group, R2 and R3 each independently represent H, methyl, or a leaving group, provided that at least one, but not both, of R2 and R3 is a leaving group. The intermediate compounds are useful for the synthesis of discodermolide, its derivatives, and related compounds.

Abstract: Provided is a cyclometalated transition metal complex represented by Formula 1, Formula 2 or Formula 3: By including a new ancillary ligand, the cyclometalated transition metal complex can efficiently emit red light using a phosphor by intersystem crossing (ISC) of excitons to triplet states and then metal to ligand charge transfer (MLCT). An organic light emitting device prepared using the transition metal compound shows high luminous efficiency and high external quantum efficiency.

Abstract: A titanium alkoxide composition is provided, as represented by the chemical formula (OC6H5N)2Ti(OC6H5NH2)2. As prepared, the compound is a crystalline substance with a hexavalent titanium atom bonded to two OC6H5NH2 groups and two OC6H5N groups with a theoretical molecular weight of 480.38, comprising 60.01% C, 5.04% H and 11.66% N.

Abstract: Provided are an organometallic complex providing highly efficient phosphorescence and an organic electroluminescence device using the same. The organometallic complex can be used to form an organic layer of the organic electroluminescence device, efficiently emits light of a wavelength corresponding to red light, and has high brightness and low operating voltage.

Abstract: A class of organic metal complexes with mixed ligands for organic light emitting diodes are designed and characterized as the formula:(L2L3M)n. In this formula: L2 is a bidentate ligand which has at least one coordinate atom of oxygen; L3 is a tridentate ligand with three chelate points; M is trivalent metal selected from the group consisting of Al, Ga, In, Tl, and Ir; and n is an integer of from 1 to 2. In Formula (3), X, Y independently represent CH or N and II, III are unsubstituted or substituted aryl or heteroalkyl groups. The substituent groups can be alkyl having 1–8 carbon atoms, halogen, cyano, amino, amido, sulfonyl, carbonyl, aryl, or heteroalkyl groups such as furan, thiophene, pyrrole, pyridine, etc.

Abstract: A catalyst compound of formula I or II: (wherein R1–R11, M, E, T, X, Y, m and n are defined herein). The compound, when combined with a suitable activator, is active for the polymerization of olefins. In an embodiment of combinations of the R1–R7 and T groups, these catalysts can engage in weak attractive non-covalent interactions with the polymer chain. In another embodiment, the R1–R11 groups in formula II exhibit weak attractive non-covalent interactions with the polymer chain.

Abstract: The invention provides methods for treating cancer and compounds that are useful for the treatment of tumors, as well as pharmaceutical compositions comprising the compounds, and synthetic methods and intermediates useful for preparing the compounds.

Abstract: The present invention is generally directed to luminescent lanthanide compounds with phosphine oxide, phosphine oxide-sulfide, pyridine N-oxide, and phosphine oxide-pyridine N-oxide ligands. It also relates to electronic devices in which the active layer includes a lanthanide complex.

Abstract: The present invention is generally directed to luminescent lanthanide compounds with phosphine oxide, phosphine oxide-sulfide, pyridine N-oxide, and phosphine oxide-pyridine N-oxide ligands. It also relates to electronic devices in which the active layer includes a lanthanide complex.

Abstract: The present invention is generally directed to luminescent lanthanide compounds with phosphine oxide, phosphine oxide-sulfide, pyridine N-oxide, and phosphine oxide-pyridine N-oxide ligands. It also relates to electronic devices in which the active layer includes a lanthanide complex.

Abstract: An organometallic complex which includes a carboxylic acid as an ancillary ligand, and an organic electroluminescent device employing the same. The organometallic complex is useful as a phosphorescence dopant material of an organic electroluminescent device due to its high luminosity in the range of the blue wavelengths.

Abstract: A metal complex and its use for binding or cleaving a nucleic acid. The metal complex has the formula: M is Pt, Pd, Ni, Co, or Cu; X is aryl, heteroaryl, cyclyl, or heterocyclyl; Y is halogen, tosylate, mesylate, triflate, pyrophosphate, or carboxylate; each of A1 and A2, independently, is N or C; each of A3 and A4, independently, is N, S, or O, wherein A1, A2, A3, and A4 taken together have one positive charge; and each of R1 and R2, independently, is alkyl, aryl, heteroaryl, alkoxyl, aryloxyl, heteroaryloxyl, alkoxylcarbonyl, aryloxylcarbonyl, or heteroaryloxylcarbonyl.

Abstract: The invention provides methods for treating cancer and compounds that are useful for the treatment of tumors, as well as pharmaceutical compositions comprising the compounds, and synthetic methods and intermediates useful for preparing the compounds.

Abstract: Vanadium (IV) complexes containing a substituted or unsubstituted catecholate ligand, and the spermicidal activity of such compounds. Preferred compounds are vanadocene (IV) complexes containing alkyl substituted catecholate ligands.